These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4170194)

  • 1. [Use of "Cernilton" in patients with prostatic hypertrophy].
    Inada T; Kitagawa T; Miyakawa M
    Hinyokika Kiyo; 1967 Jun; 13(6):466-9. PubMed ID: 4170194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy].
    Horii A; Iwai S; Maekawa M; Tsujita M
    Hinyokika Kiyo; 1985 Apr; 31(4):739-46. PubMed ID: 2412423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
    Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y
    Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
    Shaplygin LV; Sivakov AA
    Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of a preparation with pollen extract base in patients with prostatic hypertrophy].
    Inada T; Kitagawa T; Miyakawa M
    Clin Ter; 1970 Jun; 53(5):431-8. PubMed ID: 4097408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis].
    Aslamazov EG; Akhvlediani ND; Vinarov AZ; Aliaev IuG
    Urologiia; 2007; (1):52, 54-6. PubMed ID: 17472001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prazosin on patients with symptoms of benign prostatic hypertrophy.
    Steven ID; Coffey GA; Graham NM; Wlodarczyk J; Curtis P
    Aust Fam Physician; 1993 Jul; 22(7):1260-4. PubMed ID: 7690542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety in the use of doxazosin (cardura) in the treatment of patients with benign prostatic hypertrophy (bph)].
    Lopatkin NA; Aliaev IuG; Kogan MI; Loran OB; Mazo EB; Stepanov VN
    Urologiia; 2003; (5):3-4. PubMed ID: 14658262
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conservative treatment of prostatic hypertrophy with gestagens].
    Baevskiĭ IuL
    Urol Nefrol (Mosk); 1974; 39(4):31-3. PubMed ID: 4137390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral treatment of prostatic hypertrophy].
    Casella G
    Policlinico Chir; 1970; 77(5):285-90. PubMed ID: 4100812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of Eviprostat for treatment of prostatic hypertrophy].
    Ookita K; Shiraga T; Matsumura Y
    Hinyokika Kiyo; 1966 May; 12(5):511-7. PubMed ID: 4164092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of prostatic hypertrophy with depostat].
    Nuri M; Hochberg K
    Munch Med Wochenschr; 1970 May; 112(22):1057-60. PubMed ID: 4192989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Doxazosin in the treatment of benign prostatic hypertrophy].
    Rollema HJ; Janknegt RA
    J Urol (Paris); 1993; 99(6):314-5. PubMed ID: 7516377
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with SH 582 for prostatic hypertrophy].
    Kobayashi C; Miki M
    Hinyokika Kiyo; 1970 Sep; 16(9):446-9. PubMed ID: 4097358
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mepartricin as medical treatment of benign prostatic hypertrophy].
    Micali F; Giurioli A; Virgili G; Vespasiani G
    J Urol (Paris); 1993; 99(6):293-5. PubMed ID: 7516370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].
    Kogawa T; Yanagiya H; Takashima T; Higashino I; Kudo T; Suzuki T; Mikuni T; Kido K; Tsukui A; Yagihashi Y
    Hinyokika Kiyo; 1993 Mar; 39(3):281-7. PubMed ID: 7685143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results and considerations on several cases of prostatic hypertrophy treated with hydroxyprogesterone capronate].
    Tinunin O
    Minerva Urol; 1969; 21(4):107-20. PubMed ID: 4192306
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone therapy for prostatic carcinoma and hypertrophy].
    Hanschke HJ
    Dtsch Med Wochenschr; 1969 Mar; 94(13):677-8. PubMed ID: 4180637
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormone treatment of benign prostatic hypertrophy].
    Sember M; Bernstein-Hahn L
    Rev Argent Urol Nefrol; 1969 Sep; 38(9):160-1. PubMed ID: 4190461
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sabal serrulata extract in the management of symptoms of prostatic hypertrophy].
    Kondás J; Philipp V; Diószeghy G
    Orv Hetil; 1997 Feb; 138(7):419-21. PubMed ID: 9091843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.